Skip to main content

Want a detailed portfolio tracker?

Immunome (IMNM) P/E (2021 - 2026)

Immunome (IMNM) P/E from Mar 31, 2021 to Jul 21, 2026. The TTM Immunome (IMNM) P/E is -10.27. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Immunome (IMNM)

YearP/EChange
2026-10.27+6.20%
2025-9.67+336.51%
2024-2.21-93.78%
2023-35.58+718.04%
2022-4.35-88.27%
2021-37.09N/A

Comparison Immunome (IMNM) P/E with competitors

Immunome (IMNM) P/E is -10.27.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.73%
FGENFibroGen Inc0.24-102.34%
CHRSCoherus Biosciences Inc0.85-108.26%
FBIOFortress Biotech Inc0.95-109.24%
ORMPOramed Pharmaceuticals Inc1.50-114.64%
AGENAgenus Inc3.01-129.31%
INVAInnoviva Inc3.15-130.72%
VXRTVaxart Inc3.55-134.58%
CRMDCorMedix Inc3.63-135.34%
CVACCureVac N.V.4.45-143.30%
GLPGGalapagos NV4.86-147.33%
SRPTSarepta Therapeutics Inc4.88-147.55%
ABEOAbeona Therapeutics Inc5.39-152.48%
ABUSArbutus Biopharma Corp5.60-154.50%
ZVRAZevra Therapeutics Inc5.89-157.34%
SPROSpero Therapeutics Inc6.23-160.67%
CGENCompugen Ltd6.31-161.50%
RIGLRigel Pharmaceuticals6.87-166.94%
SLXNSilexion Therapeutics Corp7.30-171.07%
OMEROmeros Corporation9.26-190.18%
AUPHAurinia Pharmaceuticals Inc9.58-193.36%
PLXProtalix BioTherapeutics Inc10.89-206.08%
ACADAcadia Pharmaceuticals Inc11.73-214.24%
TBPHTheravance Biopharma Inc12.26-219.44%
ADMAAdma Biologics Inc12.42-220.96%
HRMYHarmony Biosciences Holdings Inc13.82-234.61%
SABSSAB Biotherapeutics Inc14.14-237.69%
NAGENiagen Bioscience Inc14.82-244.33%
INCYIncyte Corp15.82-254.12%
REGNRegeneron Pharmaceuticals Inc15.86-254.45%
PBYIPuma Biotechnology Inc17.32-268.66%
CPRXCatalyst Pharmaceuticals Inc17.44-269.87%
EXELExelixis Inc17.54-270.83%
TGTXTG Therapeutics Inc18.97-284.74%
MDXGMimedx Group Inc20.55-300.19%
XOMAXOMA Royalty Corp22.87-322.81%
ARGXArgen X SE24.30-336.68%
CTMXCytomX Therapeutics Inc24.82-341.77%
XOMAOXOMA Royalty Corp25.34-346.87%
HALOHalozyme Therapeutics Inc25.62-349.59%
XOMAPXOMA Royalty Corp25.67-350.04%
VRTXVertex Pharmaceuticals Inc27.99-372.69%
RPRXRoyalty Pharma plc - Class A28.69-379.43%
SLNOSoleno Therapeutics Inc29.02-382.63%
ASNDAscendis Pharma A/S30.09-393.05%
LGNDLigand Pharmaceuticals Inc - Class B37.91-469.29%
APLSApellis Pharmaceuticals Inc39.02-480.09%
BMRNBiomarin Pharmaceutical Inc42.21-511.17%
KRYSKrystal Biotech Inc45.34-541.67%
ONCBeiGene Ltd69.54-777.37%
PHARPharming Group N.V.75.03-830.80%
TECHBio-Techne Corp101.96-1093.14%
VCELVericel Corp109.92-1170.70%
ALNYAlnylam Pharmaceuticals Inc117.96-1249.05%
GMABGenmab140.29-1466.52%
TLXTelix Pharmaceuticals Ltd162.15-1679.47%
CORTCorcept Therapeutics Inc212.86-2173.37%